Discover the unmet medical needs in China

Richard Tadd Blog

Healthcare is a big topic in China at the moment, thanks to the Healthy China 2020 initiative, but there have been major reforms going on in the sector for the past 14 years as the government has sought to modernise the way disease is dealt with and radically upgrade its medical infrastructure. Part of this has involved acknowledging that there …

Why choose China for your next clinical trial?

Richard Tadd Blog

Are you looking for the right site for your next clinical trial? China may not have been on your radar, but with recent developments leading to a dramatic improvement in what it has to offer, it really should be. There are good reasons why more and more healthcare companies are choosing to work with Chinese CROs. Here are five you …

Amgen finalises investment as Chinese biopharmaceuticals seem a strong prospect in 2020

Richard Tadd Industry News

The California-based multinational giant Amgen recently finalised an investment of $2.8 billion in Chinese pharmaceuticals, and it seems that the trends of the 2010s will continue as China continues to assert itself as a major player in the global biotechnology and pharmaceutical trades. Amgen itself has aggressively expanded its global influence since 2011, doubling its geographic presence from around 50 …